A three-year longitudinal study of the incidence and clinical features of falls in patients with Parkinson's disease

Ying Wan,Xiaoyu Ren,Yarong Wei,Mingzhu Zhou,Hong He,Jing Gan,Lixia Lü,Jiaying Wu,Wei Chen
DOI: https://doi.org/10.3760/cma.j.issn.1006-7876.2014.11.009
2014-01-01
Abstract:Objective To determine the incidence and features of falls in patients with Parkinson' s disease (PD) and to investigate the risk factors of falls through a 3 years follow-up.Methods We divided 92 PD patients into 2 groups:the faller group (Unified Parkinson' s Disease Rating Scale(UPDRS)-13 ≥2) and non faller group (UPDRS-13 =0),using the UPDRS-13 item.All patients were assessed by UPDRS,Hoehn-Yahr (H&Y) stage,Minimum Mental Stage Examination (MMSE),Hamilton Anxiety Scale (HAMA),Hamilton Depression Scale (HAMD) and were enquired the presence of hallucination at baseline and followed for 3 years.Results (1) The incidence of falls rose from 14.13% (13/92) at baseline to 32.18% (28/87) after 3 years.The rate of drop-out was 5.43% (5/92).(2)At baseline,in terms of motor symptoms,the faller group was dominated by the subtype of non-tremor (9/13 vs 22/60; x2 =4.64,P =0.003) and longer duration ((7.15 ± 3.87) vs (4.12 ± 2.75) years ; t =-3.34,P =0.001),higher H&Y stage (1.0-1.5:0/13 vs 14/60; 2.0-3.0:10/13 vs 45/60; 3.5-5.0:3/13 vs 1/60; x2 =9.26,P=0.002),higher scores of UPDRS (43.85 ± 16.57 vs 31.88 ± 15.23; t =-2.53,P =0.010) and UPDRS-Ⅱ (15.31 ± 6.79 vs 8.33 ± 4.48; t =-4.61,P =0.000),higher incidence of motor fluctuation (8/13 vs 15/60; x2 =6.17,P =0.010) and dysarthria (9/13 vs 4/60; x2 =22.96,P =0.000).(3) At baseline,in terms of non-motor symptoms,the faller group was dominated by higher scores of HAMA (12.15 ±6.03vs7.95±4.73; t =-2.75,P=0.008) and HAMD (20.08 ±8.64 vs 11.12±5.67; t =-4.67,P =0.000),higher incidence of hallucination (6/13 vs 9/60 ; x2 =65.48,P =0.020) and lower scores of MMSE (20.62 ± 5.06 vs 23.64 ± 4.50 ; t =2.14,P =0.040).(4) Non-tremor subtype (OR =370.79,95% CI 2.97-462.10,P =0.016) and levodopa equivalent dosage (OR =1.01,95% CI 1.00-1.02,P =0.030) were the independent risk factors of falls in patients with PD.Conclusions The incidence of falls significantly increases as the disease progresses.PD patients with a history of falls have a tendency to suffer from more serious motor and non motor symptoms.The non-tremor subtype and levodopa equivalent dosage are associated with falls in patients with PD.
What problem does this paper attempt to address?